Strategic Investments in Digital Health Companies

The company, a spin-off from the University of Zurich, is developing software for the digital diagnosis of mental disorders that is medically certified by Swissmedic in accordance with the MDD. It standardizes, structures, and accelerates diagnostic processes.
The solution systematically records mental health symptoms, visualizes them in a clear symptom map, and generates clinically validated diagnostic recommendations. In this way, it helps professionals reach well-founded diagnostic decisions more quickly and initiate targeted treatment at an early stage. Early detection, improved diagnoses, and low-barrier access to appropriate solutions generally reduce costs and enhance the well-being of those affected.
With more than six years of research behind it, the company has been on the market since 2019. It offers Europe’s first and only clinically validated tool for mental health diagnosis.